Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Cohance Lifesciences Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
Net Profit/Loss Before Extraordinary Items And Tax343.92405.67559.73667.59467.67
      
Net CashFlow From Operating Activities288.16358.48450.91330.00383.44
Net Cash Used In Investing Activities-255.30-362.25-194.84-136.21-311.40
Net Cash Used From Financing Activities3.32-13.80-235.83-156.41-76.55
Foreign Exchange Gains / Losses1.990.000.000.000.00
      
Net Inc/Dec In Cash And Cash Equivalents38.17-17.5720.2437.38-4.51
Cash And Cash Equivalents Begin of Year47.2364.8044.567.1811.70
Cash And Cash Equivalents End Of Year85.4047.2364.8044.567.18
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
Net Profit/Loss Before Extraordinary Items And Tax343.92
Net CashFlow From Operating Activities288.16
Net Cash Used In Investing Activities-255.30
Net Cash Used From Financing Activities3.32
Foreign Exchange Gains / Losses1.99
Net Inc/Dec In Cash And Cash Equivalents38.17
Cash And Cash Equivalents Begin of Year47.23
Cash And Cash Equivalents End Of Year85.40